Abstract: The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.
Type:
Grant
Filed:
September 27, 2024
Date of Patent:
April 21, 2026
Assignee:
CODEX LABS CORPORATION
Inventors:
Marc Cornell, Barbara A. Paldus, Mark Selker, Paula Simpson-Nilsen
Abstract: The present invention is directed to compositions and methods for treating and managing symptoms associated with inflammatory skin disorders by applying a synergistic blend of plant-based actives containing at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; and (c) a biotech-derived Haberlea rhodopensis extract.
Abstract: The present disclosure relates to compositions and methods useful for dietary augmentation to provide therapeutic intervention for the treatment and management of acne-prone skin. According to one embodiment of the present disclosure, there is provided an orally administrable composition containing a therapeutically effective amount of: (a) a probiotic blend of bacterial components containing at least: (i) Lactobacillus acidophilus, (ii) Bifidobacterium lactis, an (iii) Bacillus coagulans; (b) guggul; and (c) green tea leaf.
Type:
Grant
Filed:
April 12, 2024
Date of Patent:
January 14, 2025
Assignee:
CODEX LABS CORPORATION
Inventors:
Jessica Maloh, Barbara A. Paldus, Raja Sivamani
© 2026 Justia
